CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +30,241 | $13.50 | $408K | 8,666,247 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +5,573 | $13.63 | $76K | 796,336 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +59,995 | $13.63 | $818K | 8,726,242 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +22,722 | $13.72 | $312K | 819,058 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +244,587 | $13.72 | $3.4M | 8,970,829 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +52,656 | $13.80 | $727K | 871,714 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +566,814 | $13.80 | $7.8M | 9,537,643 |
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +1,312 | $1.87 | $2K | 24,234 |
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −1,312 | $25.05 | $33K | 22,922 |
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +154 | $8.21 | $1K | 23,076 |
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −154 | $25.01 | $4K | 22,922 |
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +1,109 | $9.82 | $11K | 24,031 |
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −1,109 | $25.05 | $28K | 22,922 |
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −3,241 | $25.21 | $82K | 19,681 |
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −209 | $24.77 | $5K | 19,472 |
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −231 | $24.82 | $6K | 19,241 |
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,312 | 2,617 | ||
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −154 | 302 | ||
| 2024-11-11 | Thompson Travis Alvin CHIEF ACCOUNTING OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,109 | 12,954 | ||
| 2024-10-03 | Lee Kevin CHIEF EXECUTIVE OFFICER | Sale | −3,212 | $22.26 | $71K | 380,864 |
Page 10 of 26 · 520 trades